D. Fogelson

发表

Clomipramine in the treatment of patients with obsessive-compulsive disorder. The Clomipramine Collaborative Study Group.

M. Jenike, M. Liebowitz, H. Akiskal, 1991, Archives of general psychiatry.

Neurocognitive vulnerability factors for schizophrenia: Convergence across genetic risk studies and longitudinal trait–state studies.

K. Nuechterlein, R. Asarnow, M. Dawson, 1998 .

Testing Vulnerability Models: Stability of Potential Vulnerability Indicators Across Clinical State

K. Nuechterlein, M. Dawson, J. Mintz, 1990 .

Family Interaction Versus Individual Psychopathology

K. Nuechterlein, R. Asarnow, K. Subotnik, 1992, British Journal of Psychiatry.

Untreated Mental Illness Has Created a National Tragedy: A Pandemic of Homelessness.

R. Shader, I. Glick, D. Fogelson, 2022, Journal of clinical psychopharmacology.

Avoidant personality disorder is a separable schizophrenia-spectrum personality disorder even when controlling for the presence of paranoid and schizotypal personality disorders The UCLA family study

K. Nuechterlein, K. Kendler, M. Neale, 2007, Schizophrenia Research.

The factor structure of schizophrenia spectrum personality disorders: signs and symptoms in relatives of psychotic patients from the UCLA family members study

K. Nuechterlein, R. Asarnow, K. Subotnik, 1999, Psychiatry Research.

A naturalistic pilot study comparing haloperidol, clozapine, sertindole, and risperidone in partially responsive chronic schizophrenia or schizoaffective disorder.

D. Fogelson, D. Payne, H. Sternbach, 1997, Journal of clinical psychopharmacology.

Validity of the family history method for diagnosing schizophrenia, schizophrenia-related psychoses, and schizophrenia-spectrum personality disorders in first-degree relatives of schizophrenia probands

K. Nuechterlein, R. Asarnow, K. Subotnik, 2004, Schizophrenia Research.

Symptom differences among anxiety patients in clinics with differing treatment orientations : a pilot investigation.

J. Yager, A. Bystritsky, D. Fogelson, 1993, The Journal of psychotherapy practice and research.

The dexamethasone suppression test in psychotic disorders.

B. Cohen, G. Arana, P. Barreira, 1983, The American journal of psychiatry.

Imipramine in the treatment of obsessive-compulsive disorder with and without major depression

A. Bystritsky, D. Fogelson, 1991 .

Depressive symptoms in the early course of schizophrenia: relationship to familial psychiatric illness.

K. Nuechterlein, R. Asarnow, K. Subotnik, 1997, The American journal of psychiatry.

Clinical Outcome Following Neuroleptic Discontinuation in Patients With Remitted Recent-Onset Schizophrenia

G. Bartzokis, K. Nuechterlein, J. Mintz, 2004 .

Dialysis for schizophrenia: review of clinical trials and implications for further research.

S. Marder, D. Fogelson, T. van Putten, 1980, The American journal of psychiatry.

Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression

G. Bartzokis, K. Nuechterlein, J. Mintz, 2000, Psychopharmacology.

Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia.

G. Bartzokis, K. Nuechterlein, J. Mintz, 2001, The American journal of psychiatry.

MMPI Vulnerability Indicators for Schizophrenia and Attention Deficit Disorder: UCLA Family Study of Biological Parents of Offspring with Childhood-Onset Schizophrenia or ADHD

K. Nuechterlein, R. Asarnow, I. Gottesman, 2005, Behavior genetics.

A study of DSM-III schizophreniform disorder.

B. Cohen, H. Pope, D. Fogelson, 1982, The American journal of psychiatry.

Using carbamazepine effectively.

D. Fogelson, 1984, American Journal of Psychiatry.

Expressed emotion, fixed-dose fluphenazine decanoate maintenance, and relapse in recent-onset schizophrenia.

K. Nuechterlein, M. Dawson, M. Gitlin, 1986, Psychopharmacology bulletin.

Avoidant personality disorder symptoms in first-degree relatives of schizophrenia patients predict performance on neurocognitive measures: The UCLA family study

Catherine A. Sugar, K. Nuechterlein, C. Sugar, 2010, Schizophrenia Research.

Neurocognitive functioning and schizophrenia spectrum disorders can be independent expressions of familial liability for schizophrenia in community control children: the UCLA family study

K. Nuechterlein, R. Asarnow, D. Guthrie, 2002, Schizophrenia Research.

Schizophrenia and schizophrenia-spectrum personality disorders in the first-degree relatives of children with schizophrenia: the UCLA family study.

K H Nuechterlein, K. Nuechterlein, R. Asarnow, 2001, Archives of general psychiatry.

A Retrospective Study of Valproate in Private Psychiatric Practice

S. Jacobson, D. Fogelson, H. Sternbach, 1991 .

Interrelationships between major depression and the anxiety disorders clinical relevance

A. Bystritsky, D. Fogelson, N. Sussman, 1988 .

The structure of schizotypy: relationships between neurocognitive and personality disorder features in relatives of schizophrenic patients in the UCLA Family Study

Jim Mintz, Michael C Neale, Kenneth S Kendler, 2002, Schizophrenia Research.

Interrater reliability of the structured clinical interview for DSM-III-R, Axis II: Schizophrenia spectrum and affective spectrum disorders

K. Nuechterlein, R. Asarnow, K. Subotnik, 1991, Psychiatry Research.

Defining Treatment-Resistant Depression.

A. Leuchter, D. Fogelson, 2017, JAMA psychiatry.

Neurocognitive impairments in nonpsychotic parents of children with schizophrenia and attention-deficit/hyperactivity disorder: the University of California, Los Angeles Family Study.

K. Nuechterlein, R. Asarnow, D. Guthrie, 2002, Archives of general psychiatry.

Lamotrigine treatment of refractory bipolar disorder.

D. Fogelson, H. Sternbach, 1997, The Journal of clinical psychiatry.

Guidelines Circulated for the Prescription of Benzodiazepines Are Out of Synch with Clinical Practice and Evidence-Based Reviews

D. Fogelson, 2022, Psychotherapy and Psychosomatics.

Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia

K. Nuechterlein, R. Asarnow, K. Narr, 2018, Schizophrenia Research.

Bipolar spectrum disorder masquerading as treatment resistant unipolar depression

B. Kagan, D. Fogelson, 2020, CNS Spectrums.

Persistence of fluphenazine in plasma after decanoate withdrawal.

K. Nuechterlein, K. Midha, M. Gitlin, 1988, Journal of Clinical Psychopharmacology.

Weight gain during fluoxetine treatment.

D. Fogelson, 1991 .

Bupropion in the treatment of bipolar disorders: the same old story?

A. Bystritsky, D. Fogelson, R. Pasnau, 1992, The Journal of clinical psychiatry.